[
  {
    "ts": null,
    "headline": "White House Unveils ‘TrumpRx’ Drug-Buying Site and a Pfizer Pricing Deal",
    "summary": "The company says it gains a three-year grace period to exempt it from national-security-related tariffs.",
    "url": "https://finnhub.io/api/news?id=48922ef70e1d11f9b296d8b9faf46f9b136e3c1444b725481833e72f583c20ed",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759270980,
      "headline": "White House Unveils ‘TrumpRx’ Drug-Buying Site and a Pfizer Pricing Deal",
      "id": 136944249,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "The company says it gains a three-year grace period to exempt it from national-security-related tariffs.",
      "url": "https://finnhub.io/api/news?id=48922ef70e1d11f9b296d8b9faf46f9b136e3c1444b725481833e72f583c20ed"
    }
  },
  {
    "ts": null,
    "headline": "What TrumpRx Means For Controversial Plan To Lower U.S. Drug Prices",
    "summary": "The White House unveiled TrumpRX as a key part of the administration's plan to lower U.S. drug prices. But serious questions remain.",
    "url": "https://finnhub.io/api/news?id=93ac76ddd429a06740265adee35ea6d9b3e54d0928f18a545bba2f355d2568ed",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759269170,
      "headline": "What TrumpRx Means For Controversial Plan To Lower U.S. Drug Prices",
      "id": 136943997,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "The White House unveiled TrumpRX as a key part of the administration's plan to lower U.S. drug prices. But serious questions remain.",
      "url": "https://finnhub.io/api/news?id=93ac76ddd429a06740265adee35ea6d9b3e54d0928f18a545bba2f355d2568ed"
    }
  },
  {
    "ts": null,
    "headline": "Heard on the Street Recap: Just What the Doctor Ordered",
    "summary": "The White House announced a direct-to-consumer website for Americans to buy drugs at a discount.  The government website, named TrumpRx, would allow people to buy drugs at a discounted price negotiated by the government with cash.  It wasn't clear whether the website would be useful for the majority of Americans that are already covered by private insurance, Medicare or Medicaid.",
    "url": "https://finnhub.io/api/news?id=f5c3058528b907ca54e7d6fee5ca791c8668f97c794f43618fe8a51c09a4efd5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759268709,
      "headline": "Heard on the Street Recap: Just What the Doctor Ordered",
      "id": 136944251,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "The White House announced a direct-to-consumer website for Americans to buy drugs at a discount.  The government website, named TrumpRx, would allow people to buy drugs at a discounted price negotiated by the government with cash.  It wasn't clear whether the website would be useful for the majority of Americans that are already covered by private insurance, Medicare or Medicaid.",
      "url": "https://finnhub.io/api/news?id=f5c3058528b907ca54e7d6fee5ca791c8668f97c794f43618fe8a51c09a4efd5"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Stock Surges After Company Makes a Deal With President Trump",
    "summary": "Pfizer shares jumped 6.83% Tuesday after President Trump said the drugmaker would offer some of its drugs on a new direct-to-consumer website and would introduce new drugs to the U.S. market at reduced prices.",
    "url": "https://finnhub.io/api/news?id=7d92d7b7741021982a383fc4de2cc1217781dc0f90208cc0b66ef8179cf823cb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759266883,
      "headline": "Pfizer Stock Surges After Company Makes a Deal With President Trump",
      "id": 136943999,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Pfizer shares jumped 6.83% Tuesday after President Trump said the drugmaker would offer some of its drugs on a new direct-to-consumer website and would introduce new drugs to the U.S. market at reduced prices.",
      "url": "https://finnhub.io/api/news?id=7d92d7b7741021982a383fc4de2cc1217781dc0f90208cc0b66ef8179cf823cb"
    }
  },
  {
    "ts": null,
    "headline": "Equities Advance Despite Looming Government Shutdown; Wall Street Posts Monthly Gains",
    "summary": "US equities advanced for a third straight session on Tuesday even as the world's biggest economy app",
    "url": "https://finnhub.io/api/news?id=252431a7a6608412e5fa155cdd8c5e04a190c6c57c959077f7c5b7e14deb1d5a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759266460,
      "headline": "Equities Advance Despite Looming Government Shutdown; Wall Street Posts Monthly Gains",
      "id": 136943925,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "US equities advanced for a third straight session on Tuesday even as the world's biggest economy app",
      "url": "https://finnhub.io/api/news?id=252431a7a6608412e5fa155cdd8c5e04a190c6c57c959077f7c5b7e14deb1d5a"
    }
  },
  {
    "ts": null,
    "headline": "Drug Manufacturers Help Push US Equity Indexes Higher While Government Shutdown Looms",
    "summary": "US equity indexes rose at the close on Tuesday as gains in healthcare stocks helped offset declines",
    "url": "https://finnhub.io/api/news?id=99313131e7cf3d82c030e71c9dcfc47a822c2fd036838e289d7fe78aa2289d52",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759266345,
      "headline": "Drug Manufacturers Help Push US Equity Indexes Higher While Government Shutdown Looms",
      "id": 136944051,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "US equity indexes rose at the close on Tuesday as gains in healthcare stocks helped offset declines",
      "url": "https://finnhub.io/api/news?id=99313131e7cf3d82c030e71c9dcfc47a822c2fd036838e289d7fe78aa2289d52"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Stock Soars on Trump’s New Drug Pricing Plan. Here’s Why.",
    "summary": "The president announced a federal government website that allows Pfizer to sell medicines at low prices to cash-paying consumers.",
    "url": "https://finnhub.io/api/news?id=04fbe0d5e9ce27db4ee3192e9532cb87df0019d8869b7be49ff119c8cd315884",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759265220,
      "headline": "Pfizer Stock Soars on Trump’s New Drug Pricing Plan. Here’s Why.",
      "id": 136944001,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "The president announced a federal government website that allows Pfizer to sell medicines at low prices to cash-paying consumers.",
      "url": "https://finnhub.io/api/news?id=04fbe0d5e9ce27db4ee3192e9532cb87df0019d8869b7be49ff119c8cd315884"
    }
  },
  {
    "ts": null,
    "headline": "Stocks Settle Higher as Drug Makers and Chip Stocks Rally",
    "summary": "The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed up +0.41%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.18%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.28%. December E-mini S&P futures (ESZ25 ) rose +0.39%, and December E-mini Nasdaq futures...",
    "url": "https://finnhub.io/api/news?id=560977de8624e5089c6fe6754ae58fb8bd8bbacedc1ea7c977bd3b14a2862e71",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759264879,
      "headline": "Stocks Settle Higher as Drug Makers and Chip Stocks Rally",
      "id": 136944002,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed up +0.41%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.18%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.28%. December E-mini S&P futures (ESZ25 ) rose +0.39%, and December E-mini Nasdaq futures...",
      "url": "https://finnhub.io/api/news?id=560977de8624e5089c6fe6754ae58fb8bd8bbacedc1ea7c977bd3b14a2862e71"
    }
  },
  {
    "ts": null,
    "headline": "Stocks Post Late Rally After Trump Strikes Deal With Pfizer",
    "summary": "Gains in pharmaceutical stocks lifted indexes, despite the threat of an imminent government shutdown.",
    "url": "https://finnhub.io/api/news?id=58165ca615c2838efee6978fd1fdad750dc17a02d72693011af8e05ce8466ab1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759264680,
      "headline": "Stocks Post Late Rally After Trump Strikes Deal With Pfizer",
      "id": 136944003,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Gains in pharmaceutical stocks lifted indexes, despite the threat of an imminent government shutdown.",
      "url": "https://finnhub.io/api/news?id=58165ca615c2838efee6978fd1fdad750dc17a02d72693011af8e05ce8466ab1"
    }
  },
  {
    "ts": null,
    "headline": "These Stocks Moved the Most Today: Wolfspeed, CoreWeave, Pfizer, Intel, Spotify, Firefly, Lamb Weston, and More",
    "summary": "Stocks rallied late on Tuesday, as investors shrugged off a deadline to avert a U.S. government shutdown and U.S. consumer confidence data were weaker than expected.  Wolfspeed  rose 29% to $28.60 after the chip company said it had emerged from Chapter 11 bankruptcy.  Wolfspeed said it has reduced its total debt by about 70% and lowered its annual cash interest expense by roughly 60%.",
    "url": "https://finnhub.io/api/news?id=2c4bf07d42134547bc1a1f9698797e48cefa319f65e17de445ccce370f8200ae",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759264020,
      "headline": "These Stocks Moved the Most Today: Wolfspeed, CoreWeave, Pfizer, Intel, Spotify, Firefly, Lamb Weston, and More",
      "id": 136944258,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Stocks rallied late on Tuesday, as investors shrugged off a deadline to avert a U.S. government shutdown and U.S. consumer confidence data were weaker than expected.  Wolfspeed  rose 29% to $28.60 after the chip company said it had emerged from Chapter 11 bankruptcy.  Wolfspeed said it has reduced its total debt by about 70% and lowered its annual cash interest expense by roughly 60%.",
      "url": "https://finnhub.io/api/news?id=2c4bf07d42134547bc1a1f9698797e48cefa319f65e17de445ccce370f8200ae"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer found a way to boost its ailing stock — agree on drug pricing with TrumpRx",
    "summary": "Pfizer found a way to boost its ailing stock — agree on drug pricing with TrumpRx",
    "url": "https://finnhub.io/api/news?id=6320bc7bca953ebec8a6c112302bd1152af5f0c5958e91a373590bc70ee80c91",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759259400,
      "headline": "Pfizer found a way to boost its ailing stock — agree on drug pricing with TrumpRx",
      "id": 137110324,
      "image": "",
      "related": "PFE",
      "source": "MarketWatch",
      "summary": "Pfizer found a way to boost its ailing stock — agree on drug pricing with TrumpRx",
      "url": "https://finnhub.io/api/news?id=6320bc7bca953ebec8a6c112302bd1152af5f0c5958e91a373590bc70ee80c91"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Shares Rise on Reported Drug Pricing Deal With Trump Administration",
    "summary": "Agreement expected to lower Medicaid prices; White House plans TrumpRx site.",
    "url": "https://finnhub.io/api/news?id=22b517b9cc4eb916993e22b981daf76c6d1a1f4b2133d6f6548a3a09ce480732",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759253151,
      "headline": "Pfizer Shares Rise on Reported Drug Pricing Deal With Trump Administration",
      "id": 136937740,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Agreement expected to lower Medicaid prices; White House plans TrumpRx site.",
      "url": "https://finnhub.io/api/news?id=22b517b9cc4eb916993e22b981daf76c6d1a1f4b2133d6f6548a3a09ce480732"
    }
  },
  {
    "ts": null,
    "headline": "Top Stock Movers Now: Spotify, Pfizer, CoreWeave, Lamb Weston, and More",
    "summary": "Major U.S. equities indexes edged lower Tuesday afternoon, as a potential government shutdown loomed.",
    "url": "https://finnhub.io/api/news?id=2b49d63ed7c02b1ebcbfefaad7f57a545ee4cb6cfda4bae054e12b61dd2e27d3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759252712,
      "headline": "Top Stock Movers Now: Spotify, Pfizer, CoreWeave, Lamb Weston, and More",
      "id": 136937741,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Major U.S. equities indexes edged lower Tuesday afternoon, as a potential government shutdown loomed.",
      "url": "https://finnhub.io/api/news?id=2b49d63ed7c02b1ebcbfefaad7f57a545ee4cb6cfda4bae054e12b61dd2e27d3"
    }
  },
  {
    "ts": null,
    "headline": "CoreWeave's $14B Meta deal, Spotify CEO change, Pfizer & Trump",
    "summary": "Yahoo Finance's John Hyland tracks some of today's top market stories in this Market Minute, including CoreWeave's (CRWV) deal with Meta (META), Spotify's (SPOT) C-suite shake-up, and President Trump's deal with Pfizer (PFE). Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute.",
    "url": "https://finnhub.io/api/news?id=9fe52c145815959de8cb72ee709b79337b9d679f5ce6b4e84dda947cef6ee4eb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759252223,
      "headline": "CoreWeave's $14B Meta deal, Spotify CEO change, Pfizer & Trump",
      "id": 136937538,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Yahoo Finance's John Hyland tracks some of today's top market stories in this Market Minute, including CoreWeave's (CRWV) deal with Meta (META), Spotify's (SPOT) C-suite shake-up, and President Trump's deal with Pfizer (PFE). Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute.",
      "url": "https://finnhub.io/api/news?id=9fe52c145815959de8cb72ee709b79337b9d679f5ce6b4e84dda947cef6ee4eb"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer’s Trump Deal Eases Drug Pricing, Tariff Pressure. Drug Stocks Are Up.",
    "summary": "The president announced a federal government website that allows Pfizer to sell medicines at low prices to cash-paying consumers.",
    "url": "https://finnhub.io/api/news?id=1666c915b2da3b20d51b77899d92ea8a7a5bb5de7d9c157cdd6fe2adbce9e405",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759251960,
      "headline": "Pfizer’s Trump Deal Eases Drug Pricing, Tariff Pressure. Drug Stocks Are Up.",
      "id": 136937733,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "The president announced a federal government website that allows Pfizer to sell medicines at low prices to cash-paying consumers.",
      "url": "https://finnhub.io/api/news?id=1666c915b2da3b20d51b77899d92ea8a7a5bb5de7d9c157cdd6fe2adbce9e405"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Gets Three-Year Reprieve From Trump Pharma Tariffs",
    "summary": "Pfizer will sell some drugs at a 50% average discount on a direct-to-consumer website called TrumpRx, an initiative intended to allow Americans to pay for prescriptions at discounted rates negotiated by the government.  The deal appears to resolve two major threats facing Pfizer.  It would stave off more damaging drug pricing policies while shielding the company from future tariffs imposed by the administration’s Section 232 investigation into whether the cost of medicine represents a national security threat.",
    "url": "https://finnhub.io/api/news?id=434afea44241846ecd0a82fc2e6503b7964fbf696d5ca88f5c33d30ddd2a5043",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759251331,
      "headline": "Pfizer Gets Three-Year Reprieve From Trump Pharma Tariffs",
      "id": 136937744,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Pfizer will sell some drugs at a 50% average discount on a direct-to-consumer website called TrumpRx, an initiative intended to allow Americans to pay for prescriptions at discounted rates negotiated by the government.  The deal appears to resolve two major threats facing Pfizer.  It would stave off more damaging drug pricing policies while shielding the company from future tariffs imposed by the administration’s Section 232 investigation into whether the cost of medicine represents a national security threat.",
      "url": "https://finnhub.io/api/news?id=434afea44241846ecd0a82fc2e6503b7964fbf696d5ca88f5c33d30ddd2a5043"
    }
  },
  {
    "ts": null,
    "headline": "Trump's Plan To Lower U.S. Drug Prices Faces Big Test",
    "summary": "But Trump might get less than he bargained for as drugmakers focus on prices abroad, rather than stateside efforts.",
    "url": "https://finnhub.io/api/news?id=456cd7f18059a60e00155564da4afeaff3d33c28c548a0a16c1e0af0e445e3eb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759250909,
      "headline": "Trump's Plan To Lower U.S. Drug Prices Faces Big Test",
      "id": 136937584,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "But Trump might get less than he bargained for as drugmakers focus on prices abroad, rather than stateside efforts.",
      "url": "https://finnhub.io/api/news?id=456cd7f18059a60e00155564da4afeaff3d33c28c548a0a16c1e0af0e445e3eb"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Reaches Landmark Agreement with U.S. Government to Lower Drug Costs for American Patients",
    "summary": "NEW YORK, September 30, 2025--Pfizer Inc. (NYSE: PFE) today announced a historic agreement with the Trump Administration that will ensure U.S. patients pay lower prices for their prescription medicines while strengthening America’s role as the global leader in biopharmaceutical innovation.",
    "url": "https://finnhub.io/api/news?id=1dc9a81888b778b29663b90840116eca1c316cddf79ca2770d1a97c94da2b20d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759250700,
      "headline": "Pfizer Reaches Landmark Agreement with U.S. Government to Lower Drug Costs for American Patients",
      "id": 136937746,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "NEW YORK, September 30, 2025--Pfizer Inc. (NYSE: PFE) today announced a historic agreement with the Trump Administration that will ensure U.S. patients pay lower prices for their prescription medicines while strengthening America’s role as the global leader in biopharmaceutical innovation.",
      "url": "https://finnhub.io/api/news?id=1dc9a81888b778b29663b90840116eca1c316cddf79ca2770d1a97c94da2b20d"
    }
  },
  {
    "ts": null,
    "headline": "Alnylam Pharmaceuticals, Inc. (ALNY) Reports $492M Amvuttra Sales, Raises 2025 Revenue Guidance",
    "summary": "We recently compiled a list of the 12 Best Performing Healthcare Stocks to Buy Right Now. Alnylam Pharmaceuticals, Inc. is one of them. Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY), a leading biotech company specializing in RNA interference (RNAi) therapeutics, is advancing treatments for rare and prevalent diseases, notably transthyretin amyloidosis (ATTR). Its flagship product, Amvuttra (vutrisiran), treats […]",
    "url": "https://finnhub.io/api/news?id=b49852ef15e4db581f9c2b3f5b60c0563c6a81cfeee3b29051e4d4d0efcc6afe",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759249995,
      "headline": "Alnylam Pharmaceuticals, Inc. (ALNY) Reports $492M Amvuttra Sales, Raises 2025 Revenue Guidance",
      "id": 136937747,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "We recently compiled a list of the 12 Best Performing Healthcare Stocks to Buy Right Now. Alnylam Pharmaceuticals, Inc. is one of them. Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY), a leading biotech company specializing in RNA interference (RNAi) therapeutics, is advancing treatments for rare and prevalent diseases, notably transthyretin amyloidosis (ATTR). Its flagship product, Amvuttra (vutrisiran), treats […]",
      "url": "https://finnhub.io/api/news?id=b49852ef15e4db581f9c2b3f5b60c0563c6a81cfeee3b29051e4d4d0efcc6afe"
    }
  },
  {
    "ts": null,
    "headline": "Regeneron: Growth Catalysts Incoming",
    "summary": "Regeneron Pharmaceuticals is seeing revenue growth in key products that is now offsetting declining revenue in its previous blockbuster drug. Read why REGN is a Buy.",
    "url": "https://finnhub.io/api/news?id=bb66c6e3504758db315ceacc9eb99a4641b7f297c884b7e7544ade750efc5d34",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759249535,
      "headline": "Regeneron: Growth Catalysts Incoming",
      "id": 136939389,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1386962383/image_1386962383.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Regeneron Pharmaceuticals is seeing revenue growth in key products that is now offsetting declining revenue in its previous blockbuster drug. Read why REGN is a Buy.",
      "url": "https://finnhub.io/api/news?id=bb66c6e3504758db315ceacc9eb99a4641b7f297c884b7e7544ade750efc5d34"
    }
  },
  {
    "ts": null,
    "headline": "Trump, Pfizer announce deal to lower drug prices",
    "summary": "President Trump was joined by members of his Cabinet and Pfizer (PFE) CEO Albert Bourla in the Oval Office to announce a deal that could lower drug prices for millions of Americans. Watch Trump's announcement in the video above. Watch more expert insights and analysis on the latest market action.",
    "url": "https://finnhub.io/api/news?id=ddf808910711f3205ac80fb45a85abe7242830ab3a4dee630220418ca9b1b6ed",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759248756,
      "headline": "Trump, Pfizer announce deal to lower drug prices",
      "id": 136937748,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "President Trump was joined by members of his Cabinet and Pfizer (PFE) CEO Albert Bourla in the Oval Office to announce a deal that could lower drug prices for millions of Americans. Watch Trump's announcement in the video above. Watch more expert insights and analysis on the latest market action.",
      "url": "https://finnhub.io/api/news?id=ddf808910711f3205ac80fb45a85abe7242830ab3a4dee630220418ca9b1b6ed"
    }
  },
  {
    "ts": null,
    "headline": "Nvidia stock high, Wolfspeed exits bankruptcy, Pfiezer drug prices",
    "summary": "Yahoo Finance host Julie Hyman tracks today's top moving stocks and biggest market stories in this Market Minute, including Nvidia (NVDA) shares reaching a new intraday high, Wolfspeed's (WOLF) stock reaction to exiting Chapter 11 bankruptcy, and Pfizer (PFE) striking a deal with the Trump administration to lower drug prices. Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute.",
    "url": "https://finnhub.io/api/news?id=2d739030e86296ca74a55548514a9800353f92cb4354c828236c311ac14cdce9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759248354,
      "headline": "Nvidia stock high, Wolfspeed exits bankruptcy, Pfiezer drug prices",
      "id": 136937492,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Yahoo Finance host Julie Hyman tracks today's top moving stocks and biggest market stories in this Market Minute, including Nvidia (NVDA) shares reaching a new intraday high, Wolfspeed's (WOLF) stock reaction to exiting Chapter 11 bankruptcy, and Pfizer (PFE) striking a deal with the Trump administration to lower drug prices. Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute.",
      "url": "https://finnhub.io/api/news?id=2d739030e86296ca74a55548514a9800353f92cb4354c828236c311ac14cdce9"
    }
  },
  {
    "ts": null,
    "headline": "Why Pfizer Stock Just Popped",
    "summary": "Bowing to pressure from Washington, the company is preparing to announce price cuts on drugs for U.S. customers.",
    "url": "https://finnhub.io/api/news?id=e4ea1c5c7df24ad546d8654ff6b2b29d3b1b996f80a941c279a9364fdd704119",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759248119,
      "headline": "Why Pfizer Stock Just Popped",
      "id": 136937750,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Bowing to pressure from Washington, the company is preparing to announce price cuts on drugs for U.S. customers.",
      "url": "https://finnhub.io/api/news?id=e4ea1c5c7df24ad546d8654ff6b2b29d3b1b996f80a941c279a9364fdd704119"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Stock Rises After WSJ Reports Company Will Cut Drug Costs",
    "summary": "Pfizer shares rose 2.8% Wednesday midday after The Wall Street Journal reported the pharmaceutical company would unveil a plan, alongside the Trump administration, to cut drug costs later Tuesday. Here's what to know:    The White House also plans to unveil a direct-to-consumer website for Americans to buy medication.",
    "url": "https://finnhub.io/api/news?id=6a633f4e3f072a0287e080921366b4652de528670a7645f164a019cf9fd539e4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759247240,
      "headline": "Pfizer Stock Rises After WSJ Reports Company Will Cut Drug Costs",
      "id": 136937619,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Pfizer shares rose 2.8% Wednesday midday after The Wall Street Journal reported the pharmaceutical company would unveil a plan, alongside the Trump administration, to cut drug costs later Tuesday. Here's what to know:    The White House also plans to unveil a direct-to-consumer website for Americans to buy medication.",
      "url": "https://finnhub.io/api/news?id=6a633f4e3f072a0287e080921366b4652de528670a7645f164a019cf9fd539e4"
    }
  },
  {
    "ts": null,
    "headline": "These Stocks Are Moving the Most Today: Wolfspeed, CoreWeave, Intel, Spotify, Jefferies, Firefly, Progress Software, and More",
    "summary": "Stocks were mostly lower Tuesday with investors on edge as the deadline to avert a U.S. government shutdown neared.  Wolfspeed  rose 35% to $29.82 after the chip company said it emerged from Chapter 11 bankruptcy.  Wolfspeed said it has reduced its total debt by about 70%, and lowered its annual cash interest expense by roughly 60%.",
    "url": "https://finnhub.io/api/news?id=3dee0ae024ae76b60ced36a0db0686fd0e00b4cc024b924862232ca936223c4e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759240500,
      "headline": "These Stocks Are Moving the Most Today: Wolfspeed, CoreWeave, Intel, Spotify, Jefferies, Firefly, Progress Software, and More",
      "id": 136935955,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Stocks were mostly lower Tuesday with investors on edge as the deadline to avert a U.S. government shutdown neared.  Wolfspeed  rose 35% to $29.82 after the chip company said it emerged from Chapter 11 bankruptcy.  Wolfspeed said it has reduced its total debt by about 70%, and lowered its annual cash interest expense by roughly 60%.",
      "url": "https://finnhub.io/api/news?id=3dee0ae024ae76b60ced36a0db0686fd0e00b4cc024b924862232ca936223c4e"
    }
  },
  {
    "ts": null,
    "headline": "Goldman Sachs Raises Stake in Olema Pharmaceuticals, Inc. (OLMA)",
    "summary": "Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) is among the best fast money stocks to buy now. During the first quarter, Goldman Sachs Group Inc. expanded its holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) by 93.6%. Following the purchase of 358,412 shares, the leading bank now owns 741,329 shares of the company’s stock, translating to an investment of $2,787,000 […]",
    "url": "https://finnhub.io/api/news?id=ee5b2ab44c59136952c6553f81d9a61a3a9fbe4d3a2d5464b1d32c40d6fb3891",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759246904,
      "headline": "Goldman Sachs Raises Stake in Olema Pharmaceuticals, Inc. (OLMA)",
      "id": 136937753,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) is among the best fast money stocks to buy now. During the first quarter, Goldman Sachs Group Inc. expanded its holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) by 93.6%. Following the purchase of 358,412 shares, the leading bank now owns 741,329 shares of the company’s stock, translating to an investment of $2,787,000 […]",
      "url": "https://finnhub.io/api/news?id=ee5b2ab44c59136952c6553f81d9a61a3a9fbe4d3a2d5464b1d32c40d6fb3891"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer drug prices, Lamb Weston, Coty: Trending Tickers",
    "summary": "Market Catalysts host Julie Hyman and Yahoo Finance senior reporter Brooke DiPalma track several of the day's top trending stock tickers, including Pfizer (PFE) on its collaboration with the Trump administration to unveil new, lower drug costs; Lamb Weston (LW) shares are getting a boost on the food brand's fiscal first quarter earnings results; and Coty's (COTY) strategic review of its beauty brands. To watch more expert insights and analysis on the latest market action, check out more Market Catalysts.",
    "url": "https://finnhub.io/api/news?id=aedaae26e392abb6a19cfe0ea839116195e6f6c94aff74aabef9c96a545c6ab0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759246600,
      "headline": "Pfizer drug prices, Lamb Weston, Coty: Trending Tickers",
      "id": 136937754,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Market Catalysts host Julie Hyman and Yahoo Finance senior reporter Brooke DiPalma track several of the day's top trending stock tickers, including Pfizer (PFE) on its collaboration with the Trump administration to unveil new, lower drug costs; Lamb Weston (LW) shares are getting a boost on the food brand's fiscal first quarter earnings results; and Coty's (COTY) strategic review of its beauty brands. To watch more expert insights and analysis on the latest market action, check out more Market Catalysts.",
      "url": "https://finnhub.io/api/news?id=aedaae26e392abb6a19cfe0ea839116195e6f6c94aff74aabef9c96a545c6ab0"
    }
  },
  {
    "ts": null,
    "headline": "Top Midday Stories: Trump, Pfizer Reportedly Reach Deal to Lower Drug Prices; CoreWeave to Supply Meta With $14.2 Billion in Computing Power",
    "summary": "All three major US stock indexes were down in late-morning trading Tuesday, as a federal government",
    "url": "https://finnhub.io/api/news?id=8024fb4c8c8525875d148588f6314841e82ac015bade29308a56c78e0a034149",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759246599,
      "headline": "Top Midday Stories: Trump, Pfizer Reportedly Reach Deal to Lower Drug Prices; CoreWeave to Supply Meta With $14.2 Billion in Computing Power",
      "id": 136937542,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "All three major US stock indexes were down in late-morning trading Tuesday, as a federal government",
      "url": "https://finnhub.io/api/news?id=8024fb4c8c8525875d148588f6314841e82ac015bade29308a56c78e0a034149"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer’s obesity bet shows 14.1% weight loss in Phase IIb trial",
    "summary": "Pfizer announced it would be acquiring Metsera earlier in September 2025.",
    "url": "https://finnhub.io/api/news?id=08e76b3b61ba185646ac039a3adb3cb4fb3b51d5830f16a512b8c5f5e11fc938",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759245226,
      "headline": "Pfizer’s obesity bet shows 14.1% weight loss in Phase IIb trial",
      "id": 136937756,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Pfizer announced it would be acquiring Metsera earlier in September 2025.",
      "url": "https://finnhub.io/api/news?id=08e76b3b61ba185646ac039a3adb3cb4fb3b51d5830f16a512b8c5f5e11fc938"
    }
  },
  {
    "ts": null,
    "headline": "Metsera Posts Promising Weight-Loss Drug Results. It Could Be a Win for Pfizer.",
    "summary": "Pfizer said last week it would pay $47.50 per share for Metsera, and an extra $22.50 per share if its drugs hit certain milestones.",
    "url": "https://finnhub.io/api/news?id=042b8dcc6342fb683ad2bbf930b21e69ffc1f17b42828fc75e9099e95fd3db22",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759244520,
      "headline": "Metsera Posts Promising Weight-Loss Drug Results. It Could Be a Win for Pfizer.",
      "id": 136937585,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Pfizer said last week it would pay $47.50 per share for Metsera, and an extra $22.50 per share if its drugs hit certain milestones.",
      "url": "https://finnhub.io/api/news?id=042b8dcc6342fb683ad2bbf930b21e69ffc1f17b42828fc75e9099e95fd3db22"
    }
  },
  {
    "ts": null,
    "headline": "White House to Announce ‘TrumpRx’ Drug-Buying Website, and Deal With Pfizer",
    "summary": "WASHINGTON—The White House is planning to unveil a direct-to-consumer website for Americans to buy drugs, dubbed TrumpRx, while also announcing that  Pfizer  plans to lower prices on several of its medications in the U.S., according to people familiar with the matter.  TrumpRx would allow people to pay cash for certain drugs directly from a government website, at a discounted price negotiated by the government.  Separately, Pfizer is expected to be the first to announce a plan to lower drug costs after President  Trump  pushed companies for months to lower prices in the U.S.",
    "url": "https://finnhub.io/api/news?id=3c3fe44b457a481356d09723964336d768ccb9073c3324522eb4eee0be7d776b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759242540,
      "headline": "White House to Announce ‘TrumpRx’ Drug-Buying Website, and Deal With Pfizer",
      "id": 136937758,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "WASHINGTON—The White House is planning to unveil a direct-to-consumer website for Americans to buy drugs, dubbed TrumpRx, while also announcing that  Pfizer  plans to lower prices on several of its medications in the U.S., according to people familiar with the matter.  TrumpRx would allow people to pay cash for certain drugs directly from a government website, at a discounted price negotiated by the government.  Separately, Pfizer is expected to be the first to announce a plan to lower drug costs after President  Trump  pushed companies for months to lower prices in the U.S.",
      "url": "https://finnhub.io/api/news?id=3c3fe44b457a481356d09723964336d768ccb9073c3324522eb4eee0be7d776b"
    }
  },
  {
    "ts": null,
    "headline": "3 Market Predictions For October",
    "summary": "Explore three expert market predictions for October as the NASDAQ and S&P 500 hit highs despite economic concerns. Here's what investors need to know.",
    "url": "https://finnhub.io/api/news?id=d6e2f51b2a1cf9f9a17eedc088db033cdefede074a4474bf288bf32b71eaf975",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759236513,
      "headline": "3 Market Predictions For October",
      "id": 136937395,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2203591005/image_2203591005.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Explore three expert market predictions for October as the NASDAQ and S&P 500 hit highs despite economic concerns. Here's what investors need to know.",
      "url": "https://finnhub.io/api/news?id=d6e2f51b2a1cf9f9a17eedc088db033cdefede074a4474bf288bf32b71eaf975"
    }
  },
  {
    "ts": null,
    "headline": "7 Ideal \"Safer\" Dividend Buys From 61 September Graham Value All-Stars (GVAS)",
    "summary": "7 Ideal \"Safer\" Dividend Buys From 61 September Graham Value All-Stars (GVAS)",
    "url": "https://finnhub.io/api/news?id=7541357ddeb121bc1bfda61240900c5c56a2a915721b71f97a1ef21e576562a1",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759234564,
      "headline": "7 Ideal \"Safer\" Dividend Buys From 61 September Graham Value All-Stars (GVAS)",
      "id": 136937269,
      "image": "",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=7541357ddeb121bc1bfda61240900c5c56a2a915721b71f97a1ef21e576562a1"
    }
  },
  {
    "ts": null,
    "headline": "Metsera strengthens case for Pfizer buyout with latest study data",
    "summary": "In a Phase 2 trial, a drug at the center of the $4.9 billion deal matched the type of weight loss trajectory seen in testing of Eli Lilly’s Zepbound.",
    "url": "https://finnhub.io/api/news?id=ff9f105ff73f927b7947c777bceb56731ead2ec56670541044a859b83e5d23e6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759233000,
      "headline": "Metsera strengthens case for Pfizer buyout with latest study data",
      "id": 136937588,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "In a Phase 2 trial, a drug at the center of the $4.9 billion deal matched the type of weight loss trajectory seen in testing of Eli Lilly’s Zepbound.",
      "url": "https://finnhub.io/api/news?id=ff9f105ff73f927b7947c777bceb56731ead2ec56670541044a859b83e5d23e6"
    }
  },
  {
    "ts": null,
    "headline": "China Biologics Contract Manufacturing Research Trends and Forecast Report 2025-2035: Partnerships, CMO Expansion, Pfizer Investments and Antibody-Based Products Create Key Growth Opportunities",
    "summary": "The Chinese biologics contract manufacturing market is set to grow due to innovation in biologics, cost-efficiency, skilled labor, and regulatory support. Key opportunities include a surge in partnerships, an expanded CMO presence, investments by big pharma such as Pfizer, and a focus on antibody-based products. China Biopharm CM Market China Biopharm CM Market Distribution by Product Distribution by Product Biopharmaceutical CMOs in China Biopharmaceutical CMOs in China Dublin, Sept. 30, 2025 (",
    "url": "https://finnhub.io/api/news?id=46800161c4016a3dc0455c057f449975fb96f0090d97898b4770d94430602766",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759219980,
      "headline": "China Biologics Contract Manufacturing Research Trends and Forecast Report 2025-2035: Partnerships, CMO Expansion, Pfizer Investments and Antibody-Based Products Create Key Growth Opportunities",
      "id": 136934212,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "The Chinese biologics contract manufacturing market is set to grow due to innovation in biologics, cost-efficiency, skilled labor, and regulatory support. Key opportunities include a surge in partnerships, an expanded CMO presence, investments by big pharma such as Pfizer, and a focus on antibody-based products. China Biopharm CM Market China Biopharm CM Market Distribution by Product Distribution by Product Biopharmaceutical CMOs in China Biopharmaceutical CMOs in China Dublin, Sept. 30, 2025 (",
      "url": "https://finnhub.io/api/news?id=46800161c4016a3dc0455c057f449975fb96f0090d97898b4770d94430602766"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Just Reminded Investors Why You Should Never Count Its Stock Out",
    "summary": "The company recently announced an acquisition that will bolster its growth prospects in the GLP-1 obesity market.",
    "url": "https://finnhub.io/api/news?id=c8b1b31af9a49606da6626ee82c3f989382211642f60ab01744bbf2baf64b276",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759219200,
      "headline": "Pfizer Just Reminded Investors Why You Should Never Count Its Stock Out",
      "id": 136934213,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "The company recently announced an acquisition that will bolster its growth prospects in the GLP-1 obesity market.",
      "url": "https://finnhub.io/api/news?id=c8b1b31af9a49606da6626ee82c3f989382211642f60ab01744bbf2baf64b276"
    }
  }
]